Noveris Health Sciences is trading 7.14% up at CA$0.07 on October 1, 2026, with no confirmed catalyst.
- Available search results show no new company-specific announcement for the date; the latest listed release was its September 9 report on its annual and special meeting.
- The gain follows several volatile sessions, but the provided market context does not show a broad-market move strong enough to explain it.
- No clear catalyst or reliable report directly links the price increase to a specific event.